Sort
21,453 grants matching “tuberculosis”
Therapeutics for drug-resistant bacteria: aryl myxopyronins and arylalkylcarboxamido phloroglucinols
$662,525Richard H. Ebright · Hackensack University Medical Center · U19 · FY2019 · AI
INTERNATIONAL TRAINING PROGRAM IN EPIDEMIOLOGY OF AIDS
$662,340Columbia University Health Sciences · D43 · FY2004 · TW
An Enhanced Package of Care to Reduce Mortality in Persons with Advanced HIV Disease
$662,335Radha Rajasingham · University Of Minnesota · R01 · FY2021 · AI
A Community Mycobacterial Systems Resource
$662,260Keith M Derbyshire · Wadsworth Center · R01 · FY2016 · AI
A Community Mycobacterial Systems Resource
$662,260Keith M Derbyshire · Wadsworth Center · R01 · FY2015 · AI
Chemical disarming of drug resistance in Mycobacterium tuberculosis
$662,129Christina Leigh Stallings · Washington University · R01 · FY2019 · AI
PREVENTION, CONTROL AND ELIMINATION OF TUBERCULOSIS IN THE DISTRICT OF COLUMBIA
$662,122Nnemdi Kamanu-Elias · Dist Of Columbia Dept Of Hiv/Aids Admin · U52 · FY2010 · PS
Interplay of M. tuberculosis trehalose metabolism and its pathogenesis and drug resistance
$661,936Hyungjin Eoh · University Of Southern California · R01 · FY2023 · AI
Prevention and Treatment of Tuberculosis in the State of Oklahoma
$661,903Lauri Smithee · Oklahoma State Department Of Health · U52 · FY2014 · PS
Biomarkers to Stratify Risk of Progression from Latent TB Infection to Active
$661,749Padmini Salgame · Rbhs-New Jersey Medical School · U19 · FY2020 · AI
Harmonist: A Scalable Toolkit for Standardizing and Coordinating Data Sharing Across International Research Networks
$661,693Stephany Norah Duda · Vanderbilt University Medical Center · R24 · FY2023 · AI
Predicting neurodevelopmental risk in children born to mothers living with HIV in Kenya
$661,687Megan Song McHenry · Indiana University Indianapolis · R01 · FY2024 · HD
Biomarkers of PZA activity and it's target populations
$661,554Kyu Y Rhee · Weill Medical Coll Of Cornell Univ · U19 · FY2016 · AI
B cells and humoral immunity in tuberculosis
$661,340John R. Chan · Albert Einstein College Of Medicine · R01 · FY2013 · AI
Structures of Mtb proteins conferring susceptibility to known Mtb inhibitors
$661,332James C Sacchettini · Texas A&M University · U01 · FY2010 · GM
Clinical
$661,109Rajesh T Gandhi · Harvard University · P30 · FY2009 · AI
Simulating Protein Structures, Complexes, And Dynamics
$661,055Peter J Steinbach · Center For Information Technology · ZIA · FY2012 · CT
Pharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in Children
$660,869Awewura Jacob Kwara · University Of Florida · R01 · FY2018 · HD
Eliciting lung-localized CD4 T cell responses against Mycobacterium tuberculosis in preventive and post-exposure settings
$660,785Kevin B Urdahl · Seattle Children'S Hospital · R01 · FY2021 · AI
Mechanisms of Innate Immune Evasion by Mycobacterium Tuberculosis
$660,713Jennifer A Philips · Washington University · R01 · FY2022 · AI
TB Meningitis: Evaluating CSF Immunology to Discover Hidden Disease and Potential Immunomodulatory Therapies
$660,699David R Boulware · University Of Minnesota · R01 · FY2023 · AI
Mechanism Based Inhibition of M Tuberculosis Enzymes
$660,690John S Blanchard · Albert Einstein College Of Medicine · R01 · FY2011 · AI
Extensively Drug-Resistant Tuberculosis Among Gold Miners in South Africa
$660,654Susan E Dorman · Johns Hopkins University · R01 · FY2011 · AI
Targeting mediators of oxidative stress to limit hyperinflammatory cell death modalities during Mycobacterium tuberculosis infection
$660,642Robert Owen Watson · Vanderbilt University Medical Center · R01 · FY2024 · AI
Biology and Biosignatures of Anti-Tuberculosis Treatment Response
$660,556John T Belisle · Colorado State University · U01 · FY2015 · AI